Injectables

JUVÉDERM VOLUMA™ XC is currently the only hyaluronic acid-based filler that is FDA-approved to address signs of aging in the cheeks and midface of patients at least 21 years of age. This revolutionary treatment can add volume and fullness to the midfacial region while also helping to smooth lines and wrinkles. In clinical studies, results achieved with JUVÉDERM VOLUMA™ XC have often proved to last up to two years, sometimes longer.

Approved by the FDA for patients 22 and older, JUVÉDERM VOLBELLA® XC is a state-of-the-art injectable designed to subtly augment the lips for improved fullness and definition. In addition, this filler can help soften the appearance of lines around the mouth for a rejuvenated aesthetic. Unlike other injectables of its kind, JUVÉDERM VOLBELLA® XC is clinically proven to produce results that last up to a year—if not longer—for many patients, making it an ideal option for numerous individuals seeking to non-surgically enhance lip volume and/or minimize perioral lines.

JUVÉDERM VOLLURE™ XC is a next-generation HA filler designed to smooth the appearance of moderate to severe folds and creases. Approved by the FDA for patients at least 21 years of age, this injectable is singularly beneficial for treating nasolabial folds extending from the nose to the sides of the mouth. In clinical trials, the results of JUVÉDERM VOLLURE™ XC proved to last up to 18 months for the majority of individuals, distinguishing it as the longest-lasting filler treatment for nasolabial folds available today.

The RADIESSE® solution is composed of calcium hydroxylapatite microspheres that support collagen growth in the skin. This innovative filler can be used to smooth nasolabial folds and frown lines, as well as to augment the cheeks. Results from RADIESSE® commonly last at least a year, and they can be maintained with touch-up treatments, if desired.

Sculptra® Aesthetic is a poly-L-lactic acid-based injectable designed to address volume loss in areas such as the cheeks, temples, and around the eyes, as well as to fill deep facial wrinkles and creases. Results from Sculptra® Aesthetic are generally long-lasting, sometimes remaining visible for up to two years. To maintain the filler’s effects after this time, touch-up treatments may be needed.

Similar to BOTOX® Cosmetic, XEOMIN® works by temporarily relaxing muscles in the targeted region, inhibiting them from contracting to form lines and wrinkles. This advanced injectable treatment can often be an excellent option for reducing the appearance of fine lines, crow’s feet, creases on the forehead, and furrows between the eyebrows. Results from XEOMIN® generally last up to four months, though occasional touch-up treatments can help prolong the procedure’s rejuvenative effects.

For some people, a traditional facelift may not be necessary to comprehensively address their facial cosmetic concerns. The liquid facelift is a procedure that utilizes injectables and dermal fillers to non-surgically reduce various signs of facial aging. For qualified patients, this technique can help treat sagging skin, loss of cheek bone definition, moderate to severe lines and wrinkles, a wilting brow, hollowing of the temples, and a number of other aesthetic concerns. Depending on the patient’s unique needs and goals, a customized variety of injectable treatments will be employed to achieve a more youthful, revitalized appearance. The results from a liquid facelift can last six months to a year or more, and the effects can generally be maintained with periodical touch-up treatments.

Lip augmentation can often be a great option for individuals who feel their lips are too thin and/or undefined. Using fillers, fat injections, or a customized combination of both techniques, our doctor can add volume, improve definition, and enhance the overall shape of the lips with exceptionally natural-looking results. Following the procedure, the effects of treatment usually last six to twelve months—if not longer—and an ideal contour can generally be maintained with periodic follow-up visits thereafter.